Does Gut Microbiome have an Effect on Wilson's Disease Phenotype?

Area of Science:

• Genetics
• Metabolic Disorders
• Microbiome Research

Background:

• Wilson's Disease (WD) is a genetic metabolic disorder causing copper accumulation in organs.
• Clinical symptoms of WD are diverse and vary significantly among patients.
• The gut microbiome's role in WD pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the distinct features of intestinal microbiota in Chinese patients with Wilson's Disease.
• To correlate gut microbiota alterations with specific clinical manifestations of WD, particularly hepatic symptoms.
• To identify potential microbial biomarkers associated with WD subtypes.

Main Methods:

• Analysis of intestinal microbiota composition in Chinese WD patients.
• Comparison of gut microbial diversity and abundance between WD patients and controls (implied).
• Focus on alterations related to short-chain fatty acid (SCFA) production and specific genera like Haemophilus.

Main Results:

• A reduction in overall gut microbiota diversity was observed in WD patients with hepatic symptoms.
• A decrease in SCFA-producing bacterial genera was noted in these patients.
• An increased abundance of the Haemophilus microorganism was identified in WD patients.

Conclusions:

• Gut microbiota dysbiosis is associated with hepatic manifestations of Wilson's Disease.
• Specific changes in the gut microbiome, including reduced SCFA producers and increased Haemophilus, may contribute to WD.
• These findings offer new perspectives for understanding WD mechanisms and developing targeted therapies.